Dow Down 1.40% Nasdaq Down 1.59%

Novo Nordisk A/S (NVO)

-NYSE
47.82 Up 0.20(0.42%) 4:01PM EDT
|After Hours : 47.82 0.00 (0.00%) 4:01PM EDT - Nasdaq Real Time Price
Prev Close:47.62
Open:48.14
Bid:47.79 x 100
Ask:50.75 x 100
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:47.63 - 48.17
52wk Range:32.55 - 49.11
Volume:1,169,379
Avg Vol (3m):968,658
Market Cap:125.71B
P/E (ttm):28.63
EPS (ttm):1.67
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 0.42%125.71B
LLYUp 0.35%69.75B
PFEDown 1.42%184.84B
SNYDown 0.97%146.64B

Key Statistics

Forward P/E (1 yr):23.91
P/S (ttm):8.74
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.78
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback